TNDM - Tandem Diabetes Care, Inc.

Price Target Consensus

25.09

Consensus Target

35

High Target

23

Median Target

21

Low Target

Price Target News & Updates

Date	Analyst	Company	Price Target	News Title
2026-02-20	N/A	Mizuho Securities	$22	Tandem Diabetes price target raised to $22 from $21 at Mizuho
2026-02-20	N/A	Stifel Nicolaus	$22	Tandem Diabetes price target raised to $22 from $20 at Stifel
2026-02-20	N/A	UBS	$22	Tandem Diabetes price target raised to $22 from $17 at UBS
2026-02-20	Matt O'Brien	Piper Sandler	$21	Tandem Diabetes price target raised to $21 from $14 at Piper Sandler
2026-02-04	N/A	Stifel Nicolaus	$20	Tandem Diabetes price target raised to $20 from $16 at Stifel
2026-01-09	David Roman	Goldman Sachs	$25	Tandem Diabetes price target raised to $25 from $16 at Goldman Sachs
2025-12-18	N/A	Truist Financial	$24	Tandem Diabetes price target raised to $24 from $17 at Truist
2025-12-17	N/A	RBC Capital	$30	Tandem Diabetes price target raised to $30 from $25 at RBC Capital
2025-12-17	William Plovanic	Canaccord Genuity	$35	Tandem Diabetes price target raised to $35 from $24 at Canaccord
2025-12-17	Anthony Petrone	Mizuho Securities	$21	Tandem Diabetes price target raised to $21 from $18 at Mizuho